Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

493 results

Transcatheter tricuspid valve replacement in carcinoid heart disease: A multimodality‑guided, patient-centered approach

03 Apr 2026

A 74-year-old woman with carcinoid syndrome develops progressive NYHA III dyspnoea and marked fatigue, despite well-controlled systemic symptoms. Echocardiography reveals torrential tricuspid regurgitation with carcinoid valve involvement, while surgical risk is deemed high due to age, frailty, and systemic disease. How would your Heart Team approach...

Adnan Nadir

Author

Adnan Nadir
Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease: A Multimodality‑Guided, Patient-Centered Approach

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation

Two-year outcomes after transcatheter tricuspid repair without cross-over in the randomised TRI-FR trial

28 Mar 2026

Alex Sticchi interviews Erwan Donal on the 2-year outcomes of the TRI-FR randomised trial evaluating transcatheter tricuspid edge-to-edge repair (T-TEER) versus medical therapy alone, as presented at ACC.26 in New Orleans.

Alessandro Sticchi

Author

Alessandro Sticchi
Erwan Donal

Author

Erwan Donal
Two-year outcomes after transcatheter tricuspid repair without cross-over in the randomised TRI-FR trial

Atrial mitral and tricuspid regurgitation

23 Feb 2026

Register for free to this webinar on Thursday 9 April at 5:00pm with M. Adamo, M. Sitges and P. Lurz, D. Muraru and T. De Potter and learn about epidemiology and clinical presentation of combined MR and TR in patients with AF,...

Atrial mitral and tricuspid regurgitation

How should I treat a torrential tricuspid valve regurgitation in a young patient who remains symptomatic despite optimal medical therapy?

19 Feb 2026

A frail patient presents with worsening NYHA class III dyspnoea and peripheral oedema despite optimal medical therapy. Previously managed conservatively, severe tricuspid regurgitation has progressed to a torrential grade, with right-sided chamber dilatation and complex valve anatomy.

How would you treat this patient?

Eike Philipp Tigges

Author

Eike Philipp Tigges
Tim Ubben

Author

Timm Ubben
How should I treat a torrential tricuspid valve regurgitation in a young patient who remains symptomatic despite optimal medical therapy?

PCRonline @ ACC 2026 Scientific Sessions

12 Mar 2026

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2026 Scientific Sessions #ACC26

PCRonline @ ACC.26 Scientific Sessions

Miscellaneous complications: my worst nightmare

15 Feb 2026 – From PCR Tokyo Valves 2026

Explore the prevention and management of complications arising from transcatheter interventions in structural heart disease through challenging case analyses. This session presents real-world scenarios addressing complications encountered during TAVI, mitral, and tricuspid procedures, highlighting strategies to anticipate and manage these critical events effectively.

Miscellaneous complications: my worst nightmare

Procedural imaging for tricuspid valve interventions

15 Feb 2026 – From PCR Tokyo Valves 2026

Dedicated to procedural imaging for tricuspid valve interventions, this session elucidates anatomical and pathophysiological features critical for successful transcatheter procedures. It emphasizes technical aspects of TEE and ICE imaging, including 3D multiplanar reconstruction, and offers case-based learning to refine imaging skills and optimize procedural outcomes.

Procedural imaging for tricuspid valve interventions